# Sensoril(Ashwaganhda)for Bipolar Disorder

> **NCT00761761** · PHASE3 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 60 (actual)

## Conditions studied

- Bipolar I Disorder
- Bipolar II Disorder
- Bipolar Disorder NOS

## Interventions

- **DRUG:** Sensoril
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00761761
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761761, "Sensoril(Ashwaganhda)for Bipolar Disorder". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00761761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*